Skip to main content

Table 2 Radiologic and pathologic response after docetaxel plus doxorubicin neoadjuvant chemotherapy

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

Response

No. of Pts (%)

Radiologic response

 

   Complete response

7 (4.8)

   Partial response

93 (64.1)

   Stable disease

42 (29.0)

   Progressive disease

3 (2.1)

Pathologic complete response

 

   Yes

11 (7.6)

   No

134 (92.4)